Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journal/the-role-of-early-18-f-fdg-pet-ct-in-prediction-of-progression-free-3olaBbcDlE
References (22)
-
M. Manus, R. Hicks, J. Matthews, A. McKenzie, D. Rischin, E. Salminen, D. Ball (2003)
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 7
-
T. Szyszko, A. Al-Nahhas, R. Canelo, N. Habib, L. Jiao, H. Wasan, M. Pagou, P. Tait (2007)
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: Value of FDG PET versus computed tomographyNuclear Medicine Communications, 28
-
W. Weber (2005)
Use of PET for monitoring cancer therapy and for predicting outcome.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 46 6
-
A. Deleporte, P. Flamen, A. Hendlisz (2010)
State of the art: radiolabeled microspheres treatment for liver malignanciesExpert Opinion on Pharmacotherapy, 11
-
C. Wong, R. Salem, S. Raman, V. Gates, H. Dworkin (2002)
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRIEuropean Journal of Nuclear Medicine and Molecular Imaging, 29
-
P Therasse, SG Arbuck, EA Eisenhauer, J Wanders, RS Kaplan, L Rubinstein (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst, 92
-
G. Pöpperl, T. Helmberger, W. Münzing, R. Schmid, T. Jacobs, K. Tatsch (2005)
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.Cancer biotherapy & radiopharmaceuticals, 20 2
-
Haesun Choi, C. Charnsangavej, S. Faria, H. Macapinlac, M. Burgess, Shreyaskumar Patel, Lei Chen, D. Podoloff, R. Benjamin (2007)
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 13
-
V. Goh, A. Padhani (2006)
Imaging tumor angiogenesis: functional assessment using MDCT or MRI?Abdominal Imaging, 31
-
J. Bruix, M. Sherman, J. Llovet, M. Beaugrand, R. Lencioni, A. Burroughs, E. Christensen, L. Pagliaro, M. Colombo, J. Rodés (2001)
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.Journal of hepatology, 35 3
-
R. Wahl, H. Jacene, Y. Kasamon, M. Lodge (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 50
-
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumorsBreast Cancer, 12
-
H. Young, R. Baum, U. Cremerius, K. Herholz, O. Hoekstra, A. Lammertsma, J. Pruim, P. Price (1999)
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.European journal of cancer, 35 13
-
W. Weber (2006)
Positron emission tomography as an imaging biomarker.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 20
-
B. Nordlinger, M. Guiguet, J. Vaillant, P. Balladur, K. Boudjema, P. Bachellier, D. Jaeck, Association Chirurgie (1996)
Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patientsCancer, 77
-
R. Dierckx, A. Maes, M. Peeters, C. Wiele (2009)
FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 53 3
-
I. Taylor, R. Bennett, S. Sherriff (1978)
The blood supply of colorectal liver metastases.British Journal of Cancer, 38
-
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
-
A. Abbeele (2008)
The lessons of GIST--PET and PET/CT: a new paradigm for imaging.The oncologist, 13 Suppl 2
-
S. Larson, L. Schwartz (2006)
18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 6
-
C. Wong, R. Salem, Feng Qing, Kin Wong, David Barker, V. Gates, R. Lewandowski, Elizabeth Hill, H. Dworkin, C. Nagle (2004)
Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45 11
-
B Nordlinger, M Guiguet, JC Vaillant, P Balladur, K Boudjema, P Bachellier (1996)
Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de ChirurgieCancer, 77
- Publisher
- Springer Journals
- Copyright
- Copyright © 2012 by Springer-Verlag
- Subject
- Medicine & Public Health; Oncology; Orthopedics; Imaging / Radiology; Nuclear Medicine; Cardiology
- ISSN
- 1619-7070
- eISSN
- 1619-7089
- DOI
- 10.1007/s00259-012-2149-1
- pmid
- 22644713
- Publisher site
- See Article on Publisher Site
Abstract
Early response assessment to 90 Y-radioembolization using 18 F-FDG PET/CT is superior to RECIST and tumour density, demonstrating a correlation with tumour markers and significantly predicting PFS in patients with liver metastases. This could enable early response-adapted treatment strategies to be employed.
Journal
European Journal of Nuclear Medicine and Molecular Imaging – Springer Journals
Published: May 30, 2012